Rowan Stringer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Top Venues

Journal of medicinal chemistry

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Juraj Velcicky, Matthias R Bauer, Achim Schlapbach, Guillaume Lapointe, Arndt Meyer, Markus Vögtle, Ernst Blum, Estelle Ngo, Catherine Rolando, Pierre Nimsgern, Sylvie Teixeira-Fouchard, Hansjoerg Lehmann, Pascal Furet, Frédéric Berst, Jens Schümann, Rowan Stringer, Patrice Larger, Cindy Schmid, Catriona T Prendergast, Simone Riek, Patrick Schmutz, Sylvie Lehmann, Jörg Berghausen, Clemens Scheufler, Jean-Michel Rondeau, Christoph Burkhart, Thomas Knoepfel, Nina Gommermann
Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors. Journal of medicinal chemistry (2024)
Rowan Stringer, Tobias Kaster
Predicting the Intravenous Pharmacokinetics of Covalent Drugs in Animals and Humans. Journal of medicinal chemistry 67 (15) (2024)
Rowan Stringer, Tobias Kaster
Predicting the Intravenous Pharmacokinetics of Covalent Drugs in Animals and Humans. Journal of medicinal chemistry 67 (15) (2024)
Rowan Stringer, Tobias Kaster
Predicting the Intravenous Pharmacokinetics of Covalent Drugs in Animals and Humans. Journal of medicinal chemistry (2024)
Andreas Weiss, Edwige Lorthiois, Louise Barys, Kim S Beyer, Claudio Bomio, Heather Burks, Xueying Chen, Xiaoming Cui, Ruben de Kanter, Lekshmi Dharmarajan, Carmine Fedele, Marc Gerspacher, Daniel Alexander Guthy, Victoria Head, Ashley Jaeger, Eloísa Jiménez Núñez, Jeffrey D Kearns, Catherine Leblanc, Sauveur-Michel Maira, Jason Murphy, Helen Oakman, Nils Ostermann, Johannes Ottl, Pascal Rigollier, Danielle Roman, Christian Schnell, Richard Sedrani, Toshio Shimizu, Rowan Stringer, Andrea Vaupel, Johannes Voshol, Peter Wessels, Toni Widmer, Rainer Wilcken, Kun Xu, Frederic Zecri, Anna F Farago, Simona Cotesta, Saskia M Brachmann
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C. Cancer discovery 12 (6) (2022)
Edwige L Lorthiois, Marc Gerspacher, Kim S Beyer, Andrea Vaupel, Catherine Leblanc, Rowan Stringer, Andreas Weiss, Rainer Wilcken, Daniel A Guthy, Andreas Lingel, Claudio Bomio, Rainer Machauer, Pascal Rigollier, Johannes Ottl, Dorothee Arz, Pascal Bernet, Gaëlle Desjonqueres, Solene Dussauge, Malika Kazic-Legueux, Marie-Anne Lozac'h, Christophe Mura, Mickaël Sorge, Milen Todorov, Nicolas Warin, Florence Zink, Johannes Voshol, Frederic J Zecri, Richard C Sedrani, Nils Ostermann, Saskia M Brachmann, Simona Cotesta
JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS G12C for the Treatment of Solid Tumors. Journal of medicinal chemistry (2022)